Literature DB >> 24114143

CD8(+) T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC?

Niels Schaft1, Verena Wellner, Christian Wohn, Gerold Schuler, Jan Dörrie.   

Abstract

RNA transfection is a standard method to load dendritic cells (DC) with antigen for therapeutic cancer vaccination. While electroporation yields high transfection efficiency and satisfying expression levels, lipofection results in only few cells expressing high amounts of antigen. We compared antigen loading of human monocyte-derived DC by MelanA RNA electroporation and lipofection. No differences in phenotype or migrational capacity were detected, but lipofected DC induced stronger cytokine secretion by antigen-specific T cells and were superior in priming and boosting of MelanA-specific CD8(+) T cells. Interestingly, T cells stimulated with the differently transfected DC did not differ in their functional avidity. To determine whether the amount of antigen per cell is indeed responsible for the superiority of the lipofected DC, we increased the amount of MelanA RNA fivefold and mixed those DC with mock-electroporated ones to mimic the antigen distribution of lipofected cells. This significantly improved the stimulatory capacity, indicating that indeed the amount of antigen per cell seems to be the responsible feature for the observed superiority of lipofected DCs. These data suggest that a few DC that express high amounts of antigen are more immunogenic than many DC expressing lower amounts, although this needs to be tested in a two-armed immunogenicity trial.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24114143     DOI: 10.1007/s00262-013-1481-z

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  9 in total

1.  Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy.

Authors:  Rolf Billeskov; Yichuan Wang; Shahram Solaymani-Mohammadi; Blake Frey; Shweta Kulkarni; Peter Andersen; Else Marie Agger; Yongjun Sui; Jay A Berzofsky
Journal:  J Immunol       Date:  2017-03-27       Impact factor: 5.422

Review 2.  mRNA-based therapeutics: powerful and versatile tools to combat diseases.

Authors:  Shugang Qin; Xiaoshan Tang; Yuting Chen; Kepan Chen; Na Fan; Wen Xiao; Qian Zheng; Guohong Li; Yuqing Teng; Min Wu; Xiangrong Song
Journal:  Signal Transduct Target Ther       Date:  2022-05-21

Review 3.  Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies.

Authors:  Christian H K Lehmann; Lukas Heger; Gordon F Heidkamp; Anna Baranska; Jennifer J Lühr; Alana Hoffmann; Diana Dudziak
Journal:  Vaccines (Basel)       Date:  2016-03-28

4.  NF-κB activation triggers NK-cell stimulation by monocyte-derived dendritic cells.

Authors:  Naomi C Bosch; Reinhard E Voll; Caroline J Voskens; Stefanie Gross; Barbara Seliger; Gerold Schuler; Niels Schaft; Jan Dörrie
Journal:  Ther Adv Med Oncol       Date:  2019-12-11       Impact factor: 8.168

Review 5.  Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome?

Authors:  Yannick Willemen; Maarten Versteven; Marc Peeters; Zwi N Berneman; Evelien L J Smits
Journal:  Cancers (Basel)       Date:  2020-01-27       Impact factor: 6.639

6.  Multi-Level Computational Modeling of Anti-Cancer Dendritic Cell Vaccination Utilized to Select Molecular Targets for Therapy Optimization.

Authors:  Xin Lai; Christine Keller; Guido Santos; Niels Schaft; Jan Dörrie; Julio Vera
Journal:  Front Cell Dev Biol       Date:  2022-02-02

7.  Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation.

Authors:  Ilka Knippertz; Andrea Deinzer; Jan Dörrie; Niels Schaft; Dirk M Nettelbeck; Alexander Steinkasserer
Journal:  J Immunol Res       Date:  2016-06-29       Impact factor: 4.818

8.  Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon.

Authors:  Katrijn Broos; Kevin Van der Jeught; Janik Puttemans; Cleo Goyvaerts; Carlo Heirman; Heleen Dewitte; Rein Verbeke; Ine Lentacker; Kris Thielemans; Karine Breckpot
Journal:  Mol Ther Nucleic Acids       Date:  2016-06-21       Impact factor: 10.183

9.  Murine CD8 T-cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density.

Authors:  Connie B Gilfillan; Chensu Wang; Mona O Mohsen; Nathalie Rufer; Michael Hebeisen; Mathilde Allard; Grégory Verdeil; Darrell J Irvine; Martin F Bachmann; Daniel E Speiser
Journal:  Eur J Immunol       Date:  2019-12-10       Impact factor: 5.532

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.